ConductScience.org, home

Trial · NCT00123487

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
RandomizedSTARTEDDasatinib 140 mg QD306
RandomizedSTARTEDDasatinib 70 mg BID305
RandomizedCOMPLETEDDasatinib 140 mg QD305
RandomizedCOMPLETEDDasatinib 70 mg BID304
RandomizedNOT COMPLETEDDasatinib 140 mg QD1
RandomizedNOT COMPLETEDDasatinib 70 mg BID1
Treated With Study DrugSTARTEDDasatinib 140 mg QD304
Treated With Study DrugSTARTEDDasatinib 70 mg BID305
Treated With Study DrugCOMPLETEDDasatinib 140 mg QD0
Treated With Study DrugCOMPLETEDDasatinib 70 mg BID0
Treated With Study DrugNOT COMPLETEDDasatinib 140 mg QD304
Treated With Study DrugNOT COMPLETEDDasatinib 70 mg BID305

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00123487/flow